Stay informed with the latest updates for the inheritable blood disorders community.

COVID-19
CDC Issues Interim Recommendations for Pfizer-BioNTech COVID-19 Vaccine
CDC Issues Interim Recommendations for Pfizer-BioNTech COVID-19 Vaccine
NBDF & Community
Donald "Ziggy" Douglas Banner
Remembering Ziggy Douglas
Industry
Catalyst Announces New FDA Designation and Phase 3 MarzAA Study Design
Catalyst Announces New FDA Designation and Phase 3 MarzAA Study Design
NBDF & Community
Unlocking the Genetics of Inherited Bleeding Disorders
Unlocking the Genetics of Inherited Bleeding Disorders
Advocacy & Legislative
Drug Pricing Executive Order Roundup
Drug Pricing Executive Orders Roundup
NBDF & Community
NHF Partners with BCS Financial
NHF Partners with BCS Financial
Industry
1174384721-doses
Pfizer Announces First Participant Dosed Phase 3 Study of Marstacimab
Industry
1242454551-Medical-Trial
uniQure Announces Positive Results from Phase 3 Gene Therapy Trial
Medical
899906850 Online Activity
New Medscape Activity Includes Latest Gene Therapy Clinical Trial Updates…
Medical
A Great Opportunity to Learn More About Rare Platelet and Bleeding…
Medical
Small Study Looks at Use of Epidural Analgesia During Labor in VWD Type 1
Small Study Looks at Use of Epidural Analgesia During Labor in VWD Type 1…
NBDF & Community
Since 1972, we have been supporting basic science and pre-clinical research to expand our understanding of bleeding disorders.
Supporting the Judith Graham Pool Fellowship
Medical
First National HTC Patient Satisfaction Survey: The Results Are In
First National HTC Patient Satisfaction Survey: The Results Are In
COVID-19
COVID-19 Vaccines: What to Expect
COVID-19 Vaccines: What to Expect
Peer-Reviewed Journal Summaries
The First National Patient Satisfaction Survey of U.S. HTCs
The First National Patient Satisfaction Survey of U.S. HTCs